Cargando…
Biomarkers for Prognosis and Treatment Response in COVID-19 Patients
During a severe infection such as coronavirus disease 2019 (COVID-19), the level of almost all analytes can change, presenting a correlation with disease severity and survival; however, a biomarker cannot be translated into clinical practice for treatment guidance until it is proven to have a signif...
Autores principales: | Bivona, Giulia, Agnello, Luisa, Ciaccio, Marcello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Laboratory Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203437/ https://www.ncbi.nlm.nih.gov/pubmed/34108281 http://dx.doi.org/10.3343/alm.2021.41.6.540 |
Ejemplares similares
-
The immunological implication of the new vitamin D metabolism
por: Bivona, Giulia, et al.
Publicado: (2018) -
The Role of Vitamin D as a Biomarker in Alzheimer’s Disease
por: Bivona, Giulia, et al.
Publicado: (2021) -
COVID-19 and Alzheimer’s Disease
por: Ciaccio, Marcello, et al.
Publicado: (2021) -
Serum Vitamin D as a Biomarker in Autoimmune, Psychiatric and Neurodegenerative Diseases
por: Bivona, Giulia, et al.
Publicado: (2022) -
The Value of a Complete Blood Count (CBC) for Sepsis Diagnosis and Prognosis
por: Agnello, Luisa, et al.
Publicado: (2021)